Victory Square Technologies: A Covid vaccine is still months away; meet a company preparing to wage war against the coronavirus

Victory Square Technologies Inc (CNSX:VEST) has gone from 14 cents to 64 cents in less than two months – and for good reason. Its portfolio company, Victory Square Health, has come up with a 15-minute COVID-19 test that boasts 96.6% sensitivity. And, hot off the press, Victory’s Safetest technology has received the official green light for distribution in the 27 countries of the European Union. Meet Victory Square Technologies’ chief growth officer, Vahid Shababi, at the Proactive Virtual Forum on Tuesday October 27, from 1pm EST. CLICK HERE TO REGISTER About the event: Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts We look beyond the numbers and meet the people creating the value for shareholders The format: Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story You can watch the event afterwards on our YouTube channel CLICK HERE TO REGISTER